Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06296836 · ClinicalTrials.gov registry record · Phase 4

Effect of Continuing Versus Holding Metformin During Hospitalizations.

A Phase 4 study of Diabetes Mellitus, Type 2, sponsored by University of Illinois at Chicago.

Recruiting
Registry status
Phase 4
Development phase
300
Enrollment target
1
Study location

NCT06296836 is a Phase 4 study of Diabetes Mellitus, Type 2 that is actively recruiting participants, run by University of Illinois at Chicago. The registered enrollment target is 300 participants, below the 4,484-participant average among 348 other Diabetes Mellitus, Type 2 trials with a reported enrollment target (93% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06296836, a Phase 4 study of Diabetes Mellitus, Type 2, is actively recruiting participants, sponsored by University of Illinois at Chicago.

RECRUITING
Registry status
Phase 4
Development phase
300 participants
Enrollment target
1
Study location

Study Summary

A randomized study of continuing versus holding metformin during hospitalizations to internal medicine services to determine the effects on glucose control, acidosis, abdominal symptoms, length of stay, and mortality.

Conditions Studied

Diabetes Mellitus, Type 2

Interventions

  • DRUG Metformin

Study Locations (1)

Illinois

  • University of Illinois at Chicago - Chicago

Trial Details

FieldValue
Enrollment Target 300 participants
Start Date 2025-01-21
Est. Completion 2026-06-30
Phase Phase 4

Sponsor

University of Illinois at Chicago

430 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT06296836

The ClinicalTrials.gov registry entry for NCT06296836 describes a study currently listed as recruiting, categorized as Phase 4. The registered enrollment target is 300 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 4,484-participant average among 348 other Diabetes Mellitus, Type 2 trials with a reported enrollment target (93% lower). The listed sponsor is University of Illinois at Chicago, which has 430 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Diabetes Mellitus, Type 2 appearing as the primary indexed condition, and to 1 intervention - of which Metformin is the first listed.

NCT06296836 reports 1 study location spanning 1 distinct geographic area - top geographies include Illinois.

Frequently Asked Questions

What is clinical trial NCT06296836 about?

NCT06296836 is a clinical study titled "Effect of Continuing Versus Holding Metformin During Hospitalizations.". A randomized study of continuing versus holding metformin during hospitalizations to internal medicine services to determine the effects on glucose control, acidosis, abdominal symptoms, length of stay, and mortality.

What is the current status of trial NCT06296836?

This trial is currently recruiting. It is a Phase 4 study. The enrollment target is 300 participants. The study started on 2025-01-21. Estimated completion is 2026-06-30.

What conditions does trial NCT06296836 study?

This clinical trial studies the following conditions: Diabetes Mellitus, Type 2.

What interventions are being tested in trial NCT06296836?

The interventions under investigation include: Metformin (DRUG).

Who is sponsoring clinical trial NCT06296836?

This trial is sponsored by University of Illinois at Chicago, which has 430 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06296836 being conducted?

This trial has 1 study location across Illinois. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Diabetes Mellitus, Type 2

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Diabetes Mellitus, Type 2

All registered trials for this condition

Illinois

All trials with a study site in Illinois

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.